News

Telehealth helped Einstein Medical Center decrease readmissions and increase quality. 

Autoimmune diseases often impact many organ systems and are complex, requiring a number of specialists to manage them. Here’s a snapshot of an interesting new model that addresses care challenges of these diseases.

Slightly less than in 2018, approximately 8.5 million people signed up to obtain health insurance for 2019 through the ACA marketplace exchange. Here are five things that may or may not have affected these numbers.

The behavioral healthcare delivery system is broken. Fixing it requires rapid, radical innovation that is supported and facilitated on a national level and includes both public and private innovation.

Fluoroquinolone antibiotics can increase the occurrence of rare but serious events of ruptures or tears in the aorta, FDA said in a new warning.

Maintaining provider data has been a longstanding challenge within the healthcare industry. CAQH identified five challenges among health plans and groups and a new solution.

Next year will bring many changes to healthcare. Here’s how leading hospitals will stay ahead of the curve when it comes to increasing patient engagement.

A survey of healthcare payers from North Highland offers four revealing findings about decision makers’ insights for the future.

A new report explores how healthcare executives can equip their healthcare organizations to make informed decisions about what type of reimbursement risk to take on.

After an expanded recall of the blood pressure medication valsartan, FDA is warning the manufacturer of the carcinogenic ingredient involved.

Walgreens' new integrated support program aims to help patients with cancer manage the side effects of undergoing treatment. Here’s five things to know about it.

As pharmaceuticals grow to consume more and more of the healthcare dollar, traditional care models need to change in order to deliver the best healthcare outcomes and real value. Here are five new models on the rise.

New research from Cardinal Health Specialty Solutions has surprising findings about oncologists from meeting MACRA requirements to burnout.

A new study of Medicaid-enrolled children with disabilities has revealing findings about the impact of care coordinator services on caregivers.

We asked the Managed Healthcare Executive editorial advisory board: “What is your New Year’s resolution and how do you plan to achieve it?” Here’s what they said.

Learn how analytics can be leveraged to hyper-target members for health reminders.

In an effort to lower prescription drug prices, CMS unveiled proposed polices for 2020 to strengthen and modernize the Medicare Part C and D programs. Here’s a closer look at what CMS’ provisions entail and how they help accomplish the Administration’s four strategies.

Medicare Advantage enrollees can expect new benefits with the start of 2019. Here's what healthcare executives should know.

Two major drug recalls in the last week include an expanded recall of a widely used blood pressure medication as well as over-the-counter infant ibuprofen.

Find out how healthcare organizations and analysts feel about new Medicare Part D proposals and drug pricing.

Managed Healthcare Executive polled executives from across the industry to see how they feel about the current state-and future of-healthcare. 

While healthcare is often taken for granted in urban communities, many rural populations struggle to access care. Here’s how one healthcare organization addresses rural impediments and their effects on health.

Here’s how experts predict healthcare will unfold in 2019.

The combination of one of the country’s largest insurers and one of the country’s largest pharmacy chains will dramatically reshape the healthcare industry.

Growing up in in Limerick, Ireland, Michael J. Dowling admits his family situation was a little complicated-his mother was deaf and his father suffered from heart disease and arthritis. Read more about his early life and what led to his rise in healthcare.

The Integrated COPD Care Initiative in Alabama aims to reduce hospital readmission rates and acute to post-acute care-associated costs in COPD patients. Here are the results so far and insight from one of the program’s leaders.

FDA approved the first biosimilar to rituximab (Rituxan, Genentech) to treat non-Hodgkin lymphoma.